NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/03/2025
Voltar para busca
Dado oficial do USPTO
MY LEO PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
07/03/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 38, 42, 44
Data de depósito
29/06/2021
Data de registro
18/10/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/10/2022
Última transação
07/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
DK
Examinador
O'BRIEN, JENNIFER
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a tripartite swoosh design above the words "MY LEO PHARMA".
Titulares e representantes
Titulares
LEO Pharma A/S
Representantes
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Classificação técnica
Classes Nice
Classe 5Classe 38Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and for treatment of the skin
Classe 38
Providing online forums for information and communication about skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin
Classe 42
Scientific and medical research in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin; research in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin; pharmaceutical research and development services in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin; scientific research for medical purposes in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of medical researchproduct development and scientific research in relation to skin diseases and treatment of the skin; pharmaceutical teststesting of pharmaceuticals in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin
Classe 44
Medical services in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin; medicalhealth and pharmaceutical consultation services in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin; medical testsmedical testing for diagnostic or treatment purposes in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/03/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/02/2023
FIMP
FINAL DISPOSITION PROCESSED
10/02/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/01/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/10/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
18/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/08/2022
PUBO
PUBLISHED FOR OPPOSITION
02/08/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/08/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/07/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
13/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/06/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/06/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/06/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/06/2022
RFNT
REFUSAL PROCESSED BY IB
24/05/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/05/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/05/2022
RFRR
REFUSAL PROCESSED BY MPU
05/05/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/03/2022
CNRT
NON-FINAL ACTION WRITTEN
25/03/2022
DOCK
ASSIGNED TO EXAMINER
21/03/2022
MAFR
APPLICATION FILING RECEIPT MAILED
31/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/08/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MY LEO PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.